Examiner: AGGARWAL, SAHIL CHANDER

Tech Center 1600 • Art Units: 1623

This examiner grants 0% of resolved cases

Performance Statistics

—

Allow Rate

-60.0% vs TC avg

Total Applications

—

Interview Lift

Avg Prosecution Days

Based on 0 resolved cases, 2023–2026

§101 Eligibility

§102 Novelty

50.0%

§103 Obviousness

§112 Clarity

App #	Title	Status	Assignee
18511706	METHODS FOR MANAGING DISEASES IN CUT FLOWERS	Non-Final OA	Niacet Corporation
18503371	METHODS OF TREATING EYE PAIN AND EYE DISORDERS	Non-Final OA	Aisa Pharma, Inc.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.